Lie-Ming Xu

1.3k total citations
44 papers, 1.1k citations indexed

About

Lie-Ming Xu is a scholar working on Epidemiology, Hepatology and Complementary and alternative medicine. According to data from OpenAlex, Lie-Ming Xu has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Epidemiology, 22 papers in Hepatology and 10 papers in Complementary and alternative medicine. Recurrent topics in Lie-Ming Xu's work include Liver Disease Diagnosis and Treatment (25 papers), Liver physiology and pathology (19 papers) and Pharmacological Effects of Natural Compounds (7 papers). Lie-Ming Xu is often cited by papers focused on Liver Disease Diagnosis and Treatment (25 papers), Liver physiology and pathology (19 papers) and Pharmacological Effects of Natural Compounds (7 papers). Lie-Ming Xu collaborates with scholars based in China and United States. Lie-Ming Xu's co-authors include Francis J. Eng, Scott L. Friedman, Hsin Chieh Lin, Li‐Hsien Wang, Elvira Olaso, Kazuo Ikeda, Ping Jian, Changqing Zhao, Yang Zhou and Akulapalli Sudhakar and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Lie-Ming Xu

44 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lie-Ming Xu China 13 465 392 300 184 157 44 1.1k
Thomas Armbrust Germany 19 420 0.9× 299 0.8× 283 0.9× 58 0.3× 80 0.5× 42 1.2k
Shinwa Yamada Japan 20 399 0.9× 313 0.8× 243 0.8× 77 0.4× 67 0.4× 49 1.2k
Elmar R. Burchardt Germany 12 630 1.4× 442 1.1× 312 1.0× 32 0.2× 73 0.5× 21 1.1k
Sadataka Inuzuka Japan 16 524 1.1× 675 1.7× 263 0.9× 75 0.4× 25 0.2× 36 1.2k
Akihisa Miyazaki Japan 17 478 1.0× 422 1.1× 303 1.0× 28 0.2× 48 0.3× 47 1.2k
Ryuichiro Sakata Japan 14 494 1.1× 321 0.8× 251 0.8× 28 0.2× 60 0.4× 23 925
Christopher Hovell United Kingdom 4 826 1.8× 639 1.6× 171 0.6× 20 0.1× 96 0.6× 6 1.1k
Naeem A. Essani United States 10 191 0.4× 138 0.4× 190 0.6× 117 0.6× 141 0.9× 13 864
Christopher J. Parsons United States 11 785 1.7× 627 1.6× 356 1.2× 17 0.1× 127 0.8× 13 1.2k
Peihong Zhou United States 11 141 0.3× 95 0.2× 209 0.7× 73 0.4× 265 1.7× 28 740

Countries citing papers authored by Lie-Ming Xu

Since Specialization
Citations

This map shows the geographic impact of Lie-Ming Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lie-Ming Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lie-Ming Xu more than expected).

Fields of papers citing papers by Lie-Ming Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lie-Ming Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lie-Ming Xu. The network helps show where Lie-Ming Xu may publish in the future.

Co-authorship network of co-authors of Lie-Ming Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Lie-Ming Xu. A scholar is included among the top collaborators of Lie-Ming Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lie-Ming Xu. Lie-Ming Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Na, et al.. (2019). [Study on anti- fibrotic mechanism of Fuzheng -Huayu formula to suppress autophagy in mice].. PubMed. 27(8). 621–627. 3 indexed citations
2.
3.
Zhao, Changqing, Yang Zhou, Ping Jian, & Lie-Ming Xu. (2014). Traditional Chinese medicine for treatment of liver diseases: progress, challenges and opportunities. Journal of Integrative Medicine. 12(5). 401–408. 102 indexed citations
4.
Xu, Lie-Ming. (2013). Resolving blood stasis to improve liver microcirculation and treat chronic liver diseases. SHILAP Revista de lepidopterología. 2 indexed citations
5.
Zhang, Qin, et al.. (2013). A Randomized Controlled Study of Fuzheng Huayu Capsule for Prevention of Esophageal Variceal Bleeding in Patients with Liver Cirrhosis. Evidence-based Complementary and Alternative Medicine. 2013. 1–7. 12 indexed citations
6.
7.
8.
Li, Qing‐Ya, Jian Liang, Wei Zhang, et al.. (2012). Interleukin-10 Genotype Correlated to Deficiency Syndrome in Hepatitis B Cirrhosis. Evidence-based Complementary and Alternative Medicine. 2012. 1–6. 14 indexed citations
9.
Yang, Guanghua, Huilin Wei, Ping Jian, et al.. (2011). Patch oligodeoxynucleotide synthesis (POS): a novel method for synthesis of long DNA sequences and full-length genes. Biotechnology Letters. 34(4). 721–728. 8 indexed citations
10.
Zhang, Jie, et al.. (2009). [Effect and mechanism of salvianolic-acid B on inhibiting endothelin-1-induced contraction of human hepatic stellate cells].. PubMed. 29(1). 60–4. 4 indexed citations
11.
Xue, Dongying, et al.. (2006). [Effects of salvianolic acid B on signal transduction induced by transforming growth factor-beta1 and platelet-derived growth factor- BB in hepatic stellate cells of rats].. PubMed. 26(5). 439–42. 3 indexed citations
12.
Jiang, Jian, Shanzhong Tan, Chunyu Tan, Chenghai Liu, & Lie-Ming Xu. (2005). [Effect of FZHY recipe on elastase expression in liver fibrosis in rats].. PubMed. 13(4). 307–8. 3 indexed citations
13.
Xue, Dongying, et al.. (2004). [Salianic-acid B inhibits MAPK signaling in activated rat hepatic stellate cells].. PubMed. 12(8). 471–4. 3 indexed citations
14.
Zhao, Junfang, Chenghai Liu, Yiyang Hu, et al.. (2004). Effect of salvianolic acid B on Smad3 expression in hepatic stellate cells.. PubMed. 3(1). 102–5. 26 indexed citations
15.
Liu, Ping, Zhipeng Tang, Xiong Lu, et al.. (2004). [The role of changes of MMP-2, 9 activity in the development of liver fibrosis in rats].. PubMed. 12(5). 267–70. 2 indexed citations
16.
Yang, Changqing, Michael Zeisberg, Barbara Mosterman, et al.. (2003). Liver fibrosis: Insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors. Gastroenterology. 124(1). 147–159. 240 indexed citations
17.
Xu, Lie-Ming. (2003). Studies on treatment of fatty liver with traditional Chinese medicine. Journal of Chinese Integrative Medicine. 1(2). 138–141. 7 indexed citations
18.
Olaso, Elvira, Kazuo Ikeda, Francis J. Eng, et al.. (2001). DDR2 receptor promotes MMP-2–mediated proliferation and invasion by hepatic stellate cells. Journal of Clinical Investigation. 108(9). 1369–1378. 207 indexed citations
19.
Wang, Xianbo, Ping Liu, Zhipeng Tang, et al.. (1999). Role of injury and phenotype shift of liver sinusoidal endothelial cells in the development of portal hypertension of cirrhosis in rats. Zhongguo bingli shengli zazhi. 2 indexed citations
20.
Liu, Chenghai, Cheng Liu, Ping Liu, & Lie-Ming Xu. (1997). Seropharmalogical effects of Fuzheng Huayu decoction on rat Ito cell morphology and function in culture. World Journal of Gastroenterology. 3(4). 263–263. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Armbrust Breakdown of academic impact, for papers by Shinwa Yamada Breakdown of academic impact, for papers by Elmar R. Burchardt Breakdown of academic impact, for papers by Sadataka Inuzuka Breakdown of academic impact, for papers by Akihisa Miyazaki Breakdown of academic impact, for papers by Ryuichiro Sakata Breakdown of academic impact, for papers by Christopher Hovell Breakdown of academic impact, for papers by Naeem A. Essani Breakdown of academic impact, for papers by Christopher J. Parsons Breakdown of academic impact, for papers by Peihong Zhou
Rankless by CCL
2026